Home > Business > Supriya Lifescience inks pact with KIIT for development of oral cancer detection kit

Supriya Lifescience inks pact with KIIT for development of oral cancer detection kit


MUMBAI, OCT 23, 2023

Mumbai-based specialized active pharmaceutical ingredients (API) manufacturing company Supriya Lifescience Ltd. has collaborated with Kalinga Institute of Industrial Technology (KIIT) Bhubaneswar, to develop Quickblue, one of its kind oral cancer detection kit.

This oral cancer detection kit is designed to detect oral cancer in a cost-effective and efficient manner. This kit seamlessly detects oral cancer and could potentially reduce the need for extensive preclinical and clinical trials. The company has also filed for the patent of the Quickblue oral kit.

Supriya Lifescience Ltd Chairman Dr. Satish Wagh estimates that the Quickblue oral kit could reduce the cost of oral cancer detection significantly, eliminating the need for multiple biopsies in cases of non-healing oral ulcers.

“The high prevalence of oral cancer, with millions of cases reported globally, underscores the importance of early detection. This product is particularly relevant in India and the Asian sub-continent, where a significant percentage of oral cancer patients are found.”

“Early detection of cancer is crucial for improving treatment outcomes, and the Quickblue oral kit can contribute to saving lives by identifying oral cancer at an early stage. The development of the Quickblue oral kit is a promising advancement in the field of healthcare, with the potential to make oral cancer detection more accessible, cost-effective, and lifesaving. It addresses a critical healthcare need and underscores the importance of innovation in the pharmaceutical and healthcare industry.”

“The development of an oral cancer detection kit is in line with Supriya Lifescience’s vision of manufacturing niche products to meet unmet medical needs. This initiative represents a step towards diversifying the product portfolio of Supriya Lifescience Ltd. The company aims to expand and scale to new heights over the next decade,” added Dr. Wagh.

Commenting on the development of Quickblue, KIIT University R&D and Innovation Director General Dr. Mrutyunjay Suar said, “We are extremely proud to be part of this journey of collaborating with Supriya Lifescience Ltd for such a novel product. KIIT is committed to high-quality research and provides outstanding facilities and a supportive environment for our academics and students…KIIT has placed much emphasis on creating enabling infrastructure and facilities for advanced research in diverse areas. Our research groups of scholars and faculty members worked relentlessly with the expert team of Supriya Lifescience to develop this product. We believe this product can be a lifesaver by early detection of oral cancer.”

About admin

Leave a Reply

Your email address will not be published. Required fields are marked *